HomeVPHIF • OTCMKTS
add
Valeo Pharma Ord Shs Class A
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Revenue | 12.60M | -10.52% |
Operating expense | 4.65M | -34.42% |
Net income | -8.19M | -40.32% |
Net profit margin | -65.01 | -56.80% |
Earnings per share | — | — |
EBITDA | -620.00K | 78.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.12M | -27.12% |
Total assets | 32.20M | -29.30% |
Total liabilities | 95.23M | 18.18% |
Total equity | -63.03M | — |
Shares outstanding | 98.68M | — |
Price to book | -0.07 | — |
Return on assets | -9.14% | — |
Return on capital | -29.04% | — |
Cash Flow
Net change in cash
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Net income | -8.19M | -40.32% |
Cash from operations | 451.00K | 135.82% |
Cash from investing | — | — |
Cash from financing | -248.00K | -119.95% |
Net change in cash | 235.00K | 168.51% |
Free cash flow | 2.25M | 3,117.35% |
About
Founded
2003
Website
Employees
70
